Arvinas is a clinical-stage biopharmaceutical company focused on developing therapies that degrade disease-causing proteins using its proprietary PROTAC Discovery Engine platform. The company targets patients with debilitating and life-threatening diseases, including metastatic castrate-resistant prostate cancer and ER+/HER2- breast cancer.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.